The annotation partner you choose for a healthcare AI project produces t8he clinical ground truth your model learns from. Often, that decision carries more weight than workforce size or turnaround time.
Scale AI has established itself as one of the best-known providers of AI training data, supporting large-scale annotation programmes across industries like autonomous vehicles, defence and healthcare. For many organisations, it remains a strong choice where annotation volume and operational scale are the primary priorities.
Healthcare AI places different demands on annotation. Medical imaging datasets require consistent interpretation, complex DICOM workflows, specialist review, and quality controls that reflect how clinical decisions are made in practice. A dataset that is technically complete but clinically inconsistent limits model performance long before deployment.
That is why evaluating annotation partners for healthcare AI requires a different set of questions, which is what we’re focusing on in this guide. Rather than ranking vendors by size or market presence, we focus on the capabilities that matter most when building reliable medical imaging AI, and on matching the right type of partner to where your project is.
Scale AI Alternatives for Healthcare AI: A Quick Overview

Scale AI remains one of the most recognised names in AI data annotation. For healthcare AI teams, the more relevant question is which providers offer the clinical expertise, imaging workflows and annotation governance that medical projects specifically require.
This guide focuses on five providers healthcare AI teams are most likely to evaluate, each with a distinct approach to domain expertise, annotation technology and managed services.
| Provider | Best suited for | Key strengths |
| Aya Data | Healthcare AI, medical imaging and 3D annotation | Clinical annotation expertise, DICOM workflows, specialist reviewers, tiered QA, HIPAA-aware operations and 3D Point Cloud Annotation experts |
| Scale AI | Large-scale enterprise AI programmes | High-volume managed annotation, multimodal datasets and broad industry coverage |
| Encord | Medical imaging and data-centric AI | Annotation platform, active learning, dataset management, imaging workflows |
| V7 | Computer vision teams | AI-assisted annotation, workflow automation, support for complex imaging projects |
| Labelbox | Enterprise AI development | Annotation platform, collaborative workflows, and model-assisted labelling |
Before comparing each provider in detail, it is worth establishing the evaluation criteria that actually determine annotation quality in clinical and point cloud AI contexts.
Scale AI Alternatives for Healthcare AI: Detailed Comparisons
Healthcare AI projects vary significantly in complexity, regulatory requirements, and clinical scope. Some require large-scale annotation across multiple data modalities, while others depend on specialist expertise to produce clinically reliable ground truth for medical imaging or diagnostic models.
The following comparison highlights five leading providers that healthcare organisations commonly evaluate.
1) Aya Data

Aya Data operates as a specialist medical annotation partner rather than a general annotation platform. Medical image annotation is the core programme, built around DICOM-native workflows, specialist annotator sourcing, and quality frameworks designed for production-ready clinical datasets.
The annotation model reflects how clinical ground truth is actually produced. Annotators are recruited and trained for specific imaging modalities rather than drawn from a general crowd workforce. QA operates across multiple stages: structured review, specialist validation for ambiguous findings, and adjudication workflows when annotators disagree. IAA scores are tracked and reported by annotator and task type, not averaged across a project, giving healthcare AI teams visibility into where annotation consistency is strong and where protocols need refinement.
For programmes on a regulatory pathway, this distinction matters operationally. QA documentation is structured with FDA, SaMD and CE mark requirements in mind from the outset, not retrofitted after the dataset is delivered.
Best fit: Healthcare AI teams building toward clinical deployment or regulatory clearance, where annotation quality and governance are the primary project risks.
Strengths
- Strong focus on healthcare AI rather than general-purpose annotation.
- Experience supporting DICOM annotation and complex medical imaging workflows.
- Tiered quality assurance with specialist review and adjudication.
- HIPAA-aware operational processes designed for healthcare environments.
- Collaborative annotation guideline development to improve consistency across large datasets.
Considerations
- Best suited to organisations requiring managed annotation services rather than a self-service annotation platform.
- Its healthcare-first approach may be more specialised than required for organisations working primarily on non-clinical AI applications.
2) Scale AI
Scale AI built its reputation on delivering annotated training data at a volume and consistency that manual workflows could not match. Its strengths are clearest in autonomous vehicle programmes, defence and government contracts, and frontier LLM development.
For healthcare AI teams, two considerations are worth weighing. First, Scale AI’s workforce is optimised for high-throughput labelling tasks. Medical imaging annotation requires clinical judgement that general crowd annotators cannot reliably apply. Second, native DICOM support is not a core platform feature, which creates limitations for radiology programmes where metadata preservation matters.
Meta’s acquisition of a 49% stake has also prompted several enterprise customers to reduce their dependence on Scale AI, citing data sovereignty and competitive sensitivity concerns.
Best fit: Healthcare AI programmes where annotation volume and operational scale are the primary requirements, and where imaging workflows do not depend on native DICOM support or specialist clinical annotators.
Strengths
- Extensive experience managing enterprise-scale annotation programmes.
- Supports a broad range of data types, including images, text, video, LiDAR, and multimodal datasets.
- Mature operational processes capable of supporting large annotation volumes.
- Strong option for organisations running AI initiatives across multiple business domains.
Considerations
- Healthcare is one of several industries it supports rather than its sole area of focus.
- Organisations developing highly specialised clinical AI systems should evaluate how clinical expertise, DICOM workflows, and review processes are incorporated into individual engagements.
- Teams with stringent regulatory or clinical governance requirements may require greater visibility into annotation protocols and quality controls.
3) Encord
Encord handles DICOM and NIfTI natively, carries HIPAA and SOC 2 compliance, and uses active learning to surface high-value annotation cases as a project matures. It has seen strong adoption among academic medical institutions and healthcare AI teams running iterative imaging programmes.
The platform provides the annotation workspace but not the workforce. Teams with internal clinical annotators or established clinical partnerships get the most from it. However, teams that need to build annotation capacity alongside the tooling carry that overhead separately.
Best fit: Healthcare AI teams with internal annotation operations who need a purpose-built platform for medical imaging workflows and dataset management.
Strengths
- Purpose-built support for medical imaging datasets.
- Strong annotation tooling for computer vision and DICOM workflows.
- Active learning capabilities that help reduce annotation effort over time.
- Comprehensive dataset management and version control.
Considerations
- Primarily a software platform rather than a fully managed annotation partner.
- Clinical expertise and reviewer availability depend largely on the customer’s internal resources or external service providers.
- Organisations seeking end-to-end managed annotation may require additional operational support.
4) V7
V7 combines AI-assisted annotation with workflow automation to support computer vision projects across multiple industries, including healthcare. The platform offers tooling for medical image annotation and collaborative review, helping teams improve annotation efficiency while maintaining oversight.
Like Encord, V7 is a tooling platform. It does not supply clinical annotators or manage annotation operations. For teams with internal clinical reviewers who need a compliant annotation environment without enterprise pricing, it is a practical starting point.
Best fit: Early to mid-stage healthcare AI teams with internal clinical annotators who need a capable, compliant platform at an accessible price point.
Strengths
- AI-assisted annotation helps improve productivity.
- Strong workflow automation for imaging projects.
- Collaborative review features support distributed annotation teams.
- Well-suited to computer vision applications involving medical images.
Considerations
- A platform-first approach means organisations are typically responsible for assembling and managing annotation teams.
- Clinical review processes depend on how each customer structures their annotation programme.
- May require additional specialist expertise for highly regulated healthcare AI projects.
5) Labelbox
Labelbox is one of the most established annotation platforms in the enterprise market, with strong MLOps integrations, model-assisted labelling and collaborative review workflows. Google Cloud’s selection of Labelbox as its official LLM evaluation partner reflects its strength in large-scale, governance-focused programmes.
For healthcare imaging specifically, one development is worth noting: Labelbox deprecated its DICOM viewer in late 2024. Teams evaluating it for radiology AI should clarify the current state of medical format support before committing. Its usage-based billing model can also make spending difficult to forecast at scale.
Best fit: Enterprise AI teams evaluating Labelbox for workflow governance and MLOps integrations rather than medical imaging tooling specifically.
Strengths
- Mature enterprise annotation platform.
- Flexible workflow configuration.
- Strong collaboration and project management capabilities.
- Broad support for computer vision, NLP, and multimodal AI projects.
Considerations
- Designed primarily as an annotation platform rather than a healthcare-specific managed service.
- Clinical annotation expertise generally resides with the customer or external annotation partners.
- Healthcare teams requiring specialist reviewers may need to supplement the platform with additional services.
How to Choose the Right Healthcare Annotation Partner

Selecting an annotation partner shapes every stage of what follows: model training, clinical validation and regulatory submission. Workforce size and service breadth are the wrong filters. The provider who consistently produces clinically reliable training data and supports the operational and regulatory requirements your programme places on them is the right one.
Before signing, ask:
- Who creates and validates the annotations? Specialist clinicians, radiologists or subject matter experts should be involved in developing guidelines, reviewing complex cases and resolving disagreements, not just performing volume labelling.
- How are quality and consistency maintained? Look for structured QA processes, reviewer calibration, adjudication workflows and measurable quality metrics across the full project lifecycle.
- Can the provider support your clinical workflows? Confirm experience with the formats and modalities your project requires, including native DICOM handling where imaging is involved.
- How is patient data protected? Ask how PHI is managed at the infrastructure level, what security controls are in place, and whether operational processes align with your regulatory and contractual requirements.
- Can the provider grow with your project? Annotation requirements change as models mature. Evaluate whether the provider can scale while maintaining quality, reviewer consistency and transparent communication.
Conclusion
The annotation partner you choose shapes the clinical reliability of everything built on top of that data. Vendor comparisons are a starting point, not the decision itself. What matters is whether the provider’s operating model fits the healthcare AI system you are building.
Enterprise-scale annotation capacity suits some programmes. Clinical expertise, DICOM-native workflows, structured QA and specialist review processes suit others. As healthcare AI applications become more sophisticated and more subject to regulatory scrutiny, those capabilities increasingly determine whether a programme succeeds in production.
If you are evaluating annotation partners for an upcoming healthcare AI project, we would be glad to help. Book a 30-minute discovery call to discuss your use case, annotation requirements and quality objectives.
Frequently Asked Questions
What are the best Scale AI alternatives for healthcare AI projects?
The providers most commonly evaluated for healthcare AI annotation include Aya Data, Encord, V7 and Labelbox. The right choice depends on clinical expertise, native DICOM support, QA architecture, and whether the programme requires a managed annotation partner or a self-serve platform.
What makes healthcare annotation different from general AI annotation?
Healthcare annotation requires clinical judgement, specialist review and quality frameworks designed around diagnostic consistency rather than annotation throughput. Regulatory considerations also apply in ways that general annotation workflows are not built to address.
Why is DICOM support important for medical imaging AI?
DICOM files carry clinical metadata including Hounsfield units, slice thickness, pixel spacing and patient orientation, all of which directly influence annotation accuracy across volumetric scans. Converting DICOM to standard image formats before annotation strips that metadata. Annotations built on converted files are clinically degraded before the labelling work starts.
What is inter-annotator agreement and why does it matter?
Inter-annotator agreement measures how consistently different annotators label the same data. In medical imaging, it is tracked using Cohen’s Kappa for categorical tasks and the Dice coefficient for segmentation. High IAA predicts clinical validation performance more reliably than internal test-set accuracy and is increasingly relevant to regulatory submissions.
Why is specialist review important in radiology annotation?
Radiology findings involve diagnostic nuance that general annotators cannot reliably interpret. Specialist review reduces label variability, surfaces ambiguous cases that require adjudication, and produces training data that reflects how clinical decisions are actually made.
What should healthcare organisations look for in a radiology annotation partner?
Clinical annotator credentials, native DICOM support, structured QA with IAA measurement, adjudication workflows for disagreement cases and audit-ready documentation for regulatory submissions. Compliance certification covering HIPAA and SOC 2 is the baseline. Regulatory pathway support is the higher bar.
